News

Analys Elicera Therapeutics: Stärkta fas I-data för flaggskeppsprojekt
11 Nov 2026
Analys Elicera Therapeutics: Stärkta fas I-data för flaggskeppsprojekt
Equity Research Elicera Therapeutics
Analys Elicera Therapeutics: Lovande data från upploppet av CARMA-studiens första del
11 Aug 2026
Analys Elicera Therapeutics: Lovande data från upploppet av CARMA-studiens första del
Equity Research Elicera Therapeutics
Equity research Elicera Therapeutics, Q1 2026: Stepping up following progress
12 May 2026
Equity research Elicera Therapeutics, Q1 2026: Stepping up following progress
Equity Research Elicera Therapeutics
Analys Elicera Therapeutics: Låg dos tillräckligt för att eliminera aktivt lymfom i fyra av sex patienter
25 Aug 2025
Analys Elicera Therapeutics: Låg dos tillräckligt för att eliminera aktivt lymfom i fyra av sex patienter
Equity Research Elicera Therapeutics
Carlsquare Equity Research Nordic Life Science sector update
20 Feb 2023
Carlsquare Equity Research Nordic Life Science sector update
Equity Research Abera Bioscience
Research Update, Elicera Therapeutics: With the next clinical study in sight
23 Nov 2022
Research Update, Elicera Therapeutics: With the next clinical study in sight
Equity Research Elicera Therapeutics
Mrkt BUZZ Elicera: Lead Project Receives Significant Grant
02 Jun 2022
Mrkt BUZZ Elicera: Lead Project Receives Significant Grant
Equity Research Elicera Therapeutics
Mrkt BUZZ Elicera: Publishing can increase awareness
06 Apr 2022
Mrkt BUZZ Elicera: Publishing can increase awareness
Equity Research Elicera Therapeutics
Mrkt BUZZ Elicera: Strengthening Process and Patent Portfolio
19 Jan 2022
Mrkt BUZZ Elicera: Strengthening Process and Patent Portfolio
Equity Research Elicera Therapeutics
Initial coverage Elicera: Cell Therapy Company Under the Radar
20 Dec 2021
Initial coverage Elicera: Cell Therapy Company Under the Radar
Equity Research Elicera Therapeutics